The application of asymmetric bioreductions to the production of chiral pharmaceutical drugs

Annals of the New York Academy of Sciences

Volumn 799, Issue , 1996, Pages 612-619

  Chartrain, Michel ^a   Armstrong, Joseph ^a   Katz, Lorraine ^a   King, Steven ^a   Reddy, Jayanthi ^a   Shi, Yao Jun ^a   Tschaen, David ^a   Greasham, Randolph ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE; SULFONE DERIVATIVE;

CATALYSIS; CHIRALITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MANUFACTURE; REDUCTION;

EID: 0030448643     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb33266.x     Document Type: Conference Paper

References (18)

1. ARIENS, E. 1993. Nonchiral, homochiral, and composite chiral drugs. TIBS 14: 68-76.
2. RAUWS, A. & K. GROEN. 1994. Current regulatory (draft) guidance on chiral medicinal products: Canada, EEC, Japan, United States. Chirality 6: 72-75.
3. STINSON, S. 1994. Chiral drugs. Chem. Eng. News September: 38-72.
4. JONES, B. 1986. Enzymes in organic synthesis. Tetrahedron 42: 3351-3403.
5. KIESLICH, K. 1991. Biotransformations of industrial use. Acta Biotechnol. 11: 559-570.
6. LILLY, M. 1994. Advances in biotransformation processes. Chem. Eng. Sci. 49: 151-159.
7. CSUK, R. & B. GLANZER. 1991. Baker's yeast mediated transformations in organic chemistry. Chem. Rev. 91: 49-97.
8. NAKAMURA, K., Y. KAWAI, T. KITAYAMA, T. MIYAI, M. OGAWA, Y. MIKATA, M. HIGAKI & A. OHNO. 1989. Asymmetric reduction of ketones with microbes. Bull. Inst. Chem. Res. Kyoto Univ. 67: 157-168.
9. SERVI, S. 1990. Baker's yeast as a reagent in organic synthesis. Synthesis 1: 1-25.
10. CHARTRAIN, M., J. ARMSTRONG, L. KATZ, J. KELLER, D. MATHRE & R. GREASHAM. 1995. Asymmetric bioreduction of a β-ketoester to (R)-hydroxyester by the fungus Mortierella alpina MF 5534. J. Ferment. Bioeng. 80: 176-179.
11. KATZ, L., S. KING, R. GREASHAM & M. CHARTRAIN. 1995. Asymmetric bioreduction of a ketosulfone to the corresponding trans-hydroxysulfone by the yeast Rhodotorula rubra MY 2169. Enzyme Microb. Technol. In press.
12. REDDY, J., D. TSCHAEN, Y. J. SHI, V. PECORE, L. KATZ, R. GREASHAM & M. CHARTRAIN. 1996. Asymmetric bioreduction of a β-tetralone to its corresponding (S)-alcohol by the yeast Trichosporon capitatum MY 1890. J. Ferment. Bioeng. 81: 304-309.
13. BALDWIN, J., G. PONTICELLO & M. CHRISRY. 1989. Thieno thiopyran sulfamide derivatives: pharmaceutical composition and use. United States patent no. 4,797,413.
14. LYNCH, J., A. WALLACE, R. STUPIENSKI, E. BASKIN, C. BEARE, S. APPLEBY, J. SALATA, N. JURKIEWICZ, M. SANGUINETTI, R. STEIN, J. GEHRET, T. KOTHSTEIN, D. CLAREMON, J. ELLIOTT, J. BUTCHER, D. REMY & J. BALDWIN. 1994. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class-III agents, L-702,958 and L-706,000 [MK-499]. J. Pharmacol. Exp. Ther. 269: 541-554.
15. TSCHAEN, D., L. ABRAMSON, D. CAI, R. DESMOND, U. DOLLING, L. FREY, S. KARADY, Y. J. SHI & T. VERHOEVEN. 1995. Asymmetric synthesis of MK-0499. J. Org. Chem. 60: 4324-4330.
16. NAKAGAWA, S., T. HASHIZUME, K. MATSUDA, M. SANADA, O. OKAMOTO, H. FUKATSU & N. TANAKA. 1993. In vitro activity of a new carbapenem antibiotic, BO 2727, with potent antipseudomonal activity. Antimicrob. Agents Chemother. 37: 2756-2759.
17. HUNT, J., A. CARTER, J. MURRELL, H. DALTON, K. HALLINAN, D. CROUT, R. HOLT & J. CROSBY. 1995. Yeast-catalyzed reduction of β-ketoesters: (1) factors affecting whole-cell catalytic activity and stereoselectivity. Biocatal. Biotransform. 12: 159-178.
18. USHIO, K., K. INOUYE, K. NAKAMURA, S. OKA & A. OHNO. 1986. Stereochemical control in microbial reduction: (4) effect of cultivation conditions on the reduction of β-keto esters by methylotrophic yeasts. Tetrahedron Lett. 27: 2657-2660.